Direct oral anticoagulants (DOACs)

被引：9
|
作者：
Vazquez, Sara [1 ]
Rondina, Matthew T. [2 ,3 ,4 ]
机构：
[1] Univ Utah, Hlth Sci Ctr, Univ Healthcare Thrombosis Serv, Salt Lake City, UT USA
[2] Univ Utah, Dept Internal Med, Div Gen Internal Med, Salt Lake City, UT 84112 USA
[3] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT USA
[4] George E Wahlen Salt Lake City VAMC, Dept Internal Med, Salt Lake City, UT USA
来源：
VASCULAR MEDICINE | 2015年 / 20卷 / 06期
关键词：
anticoagulants; apixaban; dabigatran; edoxaban; rivaroxaban; thrombosis; DVT; pulmonary embolism; PATIENT;
D O I：
10.1177/1358863X15600256
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
DOACs are a new group of blood-thinner medications that may have some advantages over warfarin. A health care provider will look at several different factors to help patients decide if a DOAC is a good choice. Patients taking DOACs should discuss medication changes, a plan for taking the DOAC before and after a surgery, and any bleeding side effects with their health care provider.
引用
收藏
页码：575 / 577
页数：3
相关论文
共 50 条
  • [11] Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice
    Ferri, Nicola
    Colombo, Elisa
    Tenconi, Marco
    Baldessin, Ludovico
    Corsini, Alberto
    PHARMACEUTICS, 2022, 14 (06)
  • [12] An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery
    Johnston, S.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2016, 45 (05) : 618 - 630
  • [13] Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
    Hakeam, Hakeam A.
    Al-Sanea, Nasser
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (03) : 343 - 351
  • [14] Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
    Hakeam A. Hakeam
    Nasser Al-Sanea
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 343 - 351
  • [15] Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis
    Dadlani, Apaar
    Kays, Lindsey
    Bandikatla, Sudeepthi
    Wade, Regan
    Barve, Ashutosh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [16] Evaluation of direct oral anticoagulants (DOACs) prescriptions in geriatric hospital over 3 years
    Nahornyj, Elsa
    Goutelle, Svlain
    Bourguignon, Laurent
    de la Gastine, Blandine
    THERAPIE, 2021, 76 (03): : 191 - 200
  • [17] An update on laboratory assessment for direct oral anticoagulants (DOACs)
    Gosselin, Robert C.
    Adcock, Dorothy M.
    Douxfils, Jonathan
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 33 - 39
  • [18] Laboratory coagulation tests in patients treated by direct oral anticoagulants (DOACs)
    Sie, Pierre
    PRESSE MEDICALE, 2015, 44 (7-8): : 772 - 778
  • [19] Real-world safety profile of direct oral anticoagulants (DOACs): Disproportionality analysis of major bleeding events
    di Biase, Lazzaro
    Bonura, Adriano
    Pecoraro, Pasquale Maria
    Di Lazzaro, Vincenzo
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2025, 34 (02):
  • [20] Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment
    Goldstein, Rachel
    Jacobs, Aviya R.
    Zighan, Lana
    Gronich, Naomi
    Bialer, Meir
    Muszkat, Mordechai
    CNS DRUGS, 2023, 37 (03) : 203 - 214
12345